Szostakowski B, Morysinski T, Rutkowski P, Spalek M
Rep Pract Oncol Radiother. 2025; 29(4):437-444.
PMID: 39895956
PMC: 11785390.
DOI: 10.5603/rpor.101993.
Akolawala Q, Accardo A
ACS Appl Mater Interfaces. 2025; 17(4):5563-5577.
PMID: 39813590
PMC: 11788991.
DOI: 10.1021/acsami.4c20455.
Song Y, Yang H, Zhang Y, Liao J, Jia Y, Ma P
Sensors (Basel). 2024; 24(8).
PMID: 38676004
PMC: 11054571.
DOI: 10.3390/s24082387.
Harken A, Deoli N, Perez Campos C, Ponnaiya B, Garty G, Lee G
Biomed Opt Express. 2024; 15(4):2561-2577.
PMID: 38633084
PMC: 11019671.
DOI: 10.1364/BOE.522969.
Kim D, Kim J
J Liver Cancer. 2024; 24(1):33-46.
PMID: 38523467
PMC: 10990664.
DOI: 10.17998/jlc.2024.02.26.
The rationale for a carbon ion radiation therapy facility in Australia.
Thwaites D, Prokopovich D, Garrett R, Haworth A, Rosenfeld A, Ahern V
J Med Radiat Sci. 2023; 71 Suppl 2:59-76.
PMID: 38061984
PMC: 11011608.
DOI: 10.1002/jmrs.744.
Electrospun Drug-Loaded and Gene-Loaded Nanofibres: The Holy Grail of Glioblastoma Therapy?.
Louis L, Chee B, McAfee M, Nugent M
Pharmaceutics. 2023; 15(6).
PMID: 37376095
PMC: 10302184.
DOI: 10.3390/pharmaceutics15061649.
A systematic analysis of the particle irradiation data ensemble in the key of the microdosimetric kinetic model: Should clonogenic data be used for clinical relative biological effectiveness?.
Suarez-Garcia D, Cortes-Giraldo M, Bertolet A
Radiother Oncol. 2023; 185:109730.
PMID: 37301260
PMC: 10528084.
DOI: 10.1016/j.radonc.2023.109730.
Monte Carlo-Based Radiobiological Investigation of the Most Optimal Ion Beam Forming SOBP for Particle Therapy.
Kantemiris I, Pappas E, Lymperopoulou G, Thanasas D, Karaiskos P
J Pers Med. 2023; 13(1).
PMID: 36675684
PMC: 9864401.
DOI: 10.3390/jpm13010023.
Efficacy and safety of carbon ion radiotherapy for bone sarcomas: a systematic review and meta-analysis.
Dong M, Liu R, Zhang Q, Luo H, Wang D, Wang Y
Radiat Oncol. 2022; 17(1):172.
PMID: 36284346
PMC: 9594886.
DOI: 10.1186/s13014-022-02089-0.
The Majority of United States Citizens With Cancer do not Have Access to Carbon Ion Radiotherapy.
Foote R, Tsujii H, Imai R, Tsuji H, Hug E, Kanai T
Front Oncol. 2022; 12:954747.
PMID: 35875126
PMC: 9304691.
DOI: 10.3389/fonc.2022.954747.
National Effort to Re-Establish Heavy Ion Cancer Therapy in the United States.
Pompos A, Foote R, Koong A, Le Q, Mohan R, Paganetti H
Front Oncol. 2022; 12:880712.
PMID: 35774126
PMC: 9238353.
DOI: 10.3389/fonc.2022.880712.
Physics and biomedical challenges of cancer therapy with accelerated heavy ions.
Durante M, Debus J, Loeffler J
Nat Rev Phys. 2021; 3(12):777-790.
PMID: 34870097
PMC: 7612063.
DOI: 10.1038/s42254-021-00368-5.
Amifostine (WR-2721) Mitigates Cognitive Injury Induced by Heavy Ion Radiation in Male Mice and Alters Behavior and Brain Connectivity.
Boutros S, Zimmerman B, Nagy S, Lee J, Perez R, Raber J
Front Physiol. 2021; 12:770502.
PMID: 34867479
PMC: 8637850.
DOI: 10.3389/fphys.2021.770502.
Landscape of Carbon Ion Radiotherapy in Prostate Cancer: Clinical Application and Translational Research.
Chen X, Yu Q, Li P, Fu S
Front Oncol. 2021; 11:760752.
PMID: 34804961
PMC: 8602827.
DOI: 10.3389/fonc.2021.760752.
Radiosensitization Effect of Gold Nanoparticles in Proton Therapy.
Cunningham C, de Kock M, Engelbrecht M, Miles X, Slabbert J, Vandevoorde C
Front Public Health. 2021; 9:699822.
PMID: 34395371
PMC: 8358148.
DOI: 10.3389/fpubh.2021.699822.
Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance.
Wu W, Klockow J, Zhang M, Lafortune F, Chang E, Jin L
Pharmacol Res. 2021; 171:105780.
PMID: 34302977
PMC: 8384724.
DOI: 10.1016/j.phrs.2021.105780.
Application of Carbon Ion and Its Sensitizing Agent in Cancer Therapy: A Systematic Review.
Wang X, Chen X, Li G, Han X, Gao T, Liu W
Front Oncol. 2021; 11:708724.
PMID: 34290989
PMC: 8287631.
DOI: 10.3389/fonc.2021.708724.
Carbon ion radiotherapy eradicates medulloblastomas with chromothripsis in an orthotopic Li-Fraumeni patient-derived mouse model.
Simovic M, Bolkestein M, Moustafa M, Wong J, Korber V, Benedetto S
Neuro Oncol. 2021; 23(12):2028-2041.
PMID: 34049392
PMC: 8643436.
DOI: 10.1093/neuonc/noab127.
Estimating the Number of Patients Eligible for Carbon Ion Radiotherapy in the United States.
Malouff T, Vallow L, Seneviratne D, Mahajan A, Foote R, Hoppe B
Int J Part Ther. 2020; 7(2):31-41.
PMID: 33274255
PMC: 7707324.
DOI: 10.14338/IJPT-19-00079.1.
